HBA1c and Diagnosis of Type 2 Diabetes

NCT01184768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3509

Last updated 2011-07-20

No results posted yet for this study

Summary

Following the 6th Tromso study subjects with HbA1c \> 5.7 plus a subsample of subjects with lower hba1c values will be invited to an oral glucose tolerance test to see the predictive value of HBA1c in the diagnosis of type 2 diabetes.

Conditions

Sponsors & Collaborators

  • University of Tromso

    lead OTHER

Principal Investigators

  • rolf jorde, md · University of Tromso

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-10-31
Completion
2010-11-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01184768 on ClinicalTrials.gov